DOTmed: Franken questions lack of incentives for devices to treat rare diseases
Posted in News Clips on August 3rd, 2010Senator Al Franken (D-MN) questioned a panel during a Senate Health, Education, Labor and Pensions Committee Hearing on why medical device manufacturers do not have as many incentives to create treatments for rare diseases as do drug manufacturers. Franken said he would be specifically requesting the General Accountability Office (GAO) to investigate and analyze how the incentives for the drug industry compare to those in the device industry.
The hearing was billed “Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures.”




